Matching slides 110,471
Current window 40,261-40,290
Pages 3,683
Rows per page 30
Component: Listclear collectionreset all

Component

40,261-40,290 of 110,471

filter-aware
04
The slide uses a four-column layout to categorize strategic initiatives, with a summary footer providing a high-level financial outcome (Adjusted EBITDA margin improvement).GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations Beat · What IsLoop · Aha Moment2 hits
05
GMS | Results Presentation Deck | 20 slidesGMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations Beat · What IsLoop · Aha Moment2 hits
14
The slide uses external news clippings to validate market momentum and government support for EV adoption.Gogoro | Investor Presentation Deck | 27 slides · Gogoro
Pitch deck Investor relations Loop · Why Now2 hits
10
Includes a valuation table and key performance indicators.Grove | Investor Presentation Deck | 41 slides · Grove Collaborative
Pitch deck Investor relations Beat · Rising Success2 hits
23
The chart shows a clear downward trend in operating expenses over time.Grove | Investor Presentation Deck | 41 slides · Grove Collaborative
Pitch deck Investor relations Beat · Ultimate Achievement2 hits
06
Hagerty | Investor Presentation Deck | 18 slidesHagerty | Investor Presentation Deck | 18 slides · Hagerty
Conference presentation Investor relations Beat · Solution2 hits
42
The slide highlights four key board committees and three diversity/independence metrics for the board.Hanmi Financial | Results Presentation Deck | 47 slides · Hanmi Financial
Conference presentation Investor relations Loop · Cost Of Inaction2 hits
03
HeartBeam | Results Presentation Deck | 10 slidesHeartBeam | Results Presentation Deck | 10 slides · HeartBeam
Conference presentation Investor relations Beat · Attention2 hits
12
The slide details two main pillars of optimization: charter consolidation and operational/branch efficiency.Heartland Financial USA | Results Presentation Deck | 53 slides · HTLF
Conference presentation Investor relations Beat · Rising SuccessLoop · Cost Of Inaction2 hits
14
The slide highlights capital strength through both organic growth (retained earnings) and capital issuance (preferred stock and sub debt).Heartland Financial USA | Results Presentation Deck | 53 slides · HTLF
Conference presentation Investor relations Beat · Rising Success2 hits
04
The slide is partially cropped, showing only the top section of the content.Houlihan Lokey | Investor Presentation Deck | 33 slides · Houlihan Lokey
Pitch deck Investor relations Beat · ProductLoop · Golden Circle2 hits
15
The slide uses a two-part structure: service expansion lists for two time periods, followed by a grid of acquisition logos with dates.Houlihan Lokey | Investor Presentation Deck | 33 slides · Houlihan Lokey
Pitch deck Investor relations 2 hits
18
Houlihan Lokey | Investor Presentation Deck | 33 slidesHoulihan Lokey | Investor Presentation Deck | 33 slides · Houlihan Lokey
Pitch deck Investor relations Beat · Business Model2 hits
57
The slide uses a three-column layout: Actions, Enablers, and Financial Ambitions.Hugo Boss | Investor Day Presentation Deck | 107 slides · Hugo Boss
Conference presentation Investor relations Beat · VisualizationLoop · Pareto Focus2 hits
60
Hugo Boss | Investor Day Presentation Deck | 107 slidesHugo Boss | Investor Day Presentation Deck | 107 slides · Hugo Boss
Conference presentation Investor relations Beat · VisualizationLoop · Pareto Focus2 hits
62
The slide uses a three-column layout: Actions, Enablers, and Financial Ambitions.Hugo Boss | Investor Day Presentation Deck | 107 slides · Hugo Boss
Conference presentation Investor relations Beat · VisualizationLoop · Jobs To Be Done2 hits
64
The slide uses a 'Push' strategy framework to outline CRM and loyalty initiatives.Hugo Boss | Investor Day Presentation Deck | 107 slides · Hugo Boss
Conference presentation Investor relations Beat · VisualizationLoop · Jobs To Be Done2 hits
14
Includes a disclaimer about 2023 figures representing guidance midpoints.Hyperfine | Investor Presentation Deck | 16 slides · Hyperfine
Pitch deck Investor relations Beat · Financial ProfileLoop · Quick Win Big Bet2 hits
10
Uses stacked bar charts to illustrate cost and working capital reduction.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations 2 hits
15
The slide uses a combination of infographic icons for load comparison and a bar chart for infrastructure requirements.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations 2 hits
16
Hyzon | Investor Conference Presentation Deck | 24 slidesHyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations 2 hits
03
The slide highlights two distinct pipelines: TSTx (Tissue Specific Therapeutics) and NextGen CAR-T.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem (Identify pain)2 hits
09
The slide uses a two-column layout to separate milestones by drug candidate.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction2 hits
14
Includes a comparison table of clinical outcomes (ORR/CR) for NXC-201 vs competitors.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet2 hits
16
The slide compares two disease indications side-by-side with clinical metrics and competitive market context.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet2 hits
41
The slide is divided into two sections: ImmixBio Clinical Advisory Board (top) and Selected Nexcella Scientific Advisory Board Members (bottom).Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations 2 hits
43
Immix Biopharma | Investor Presentation Deck | 46 slidesImmix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations 2 hits
14
The slide uses a two-column layout to track progress for two distinct drug programs.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution2 hits
18
Includes a comparative table of clinical outcomes (ORR/CR) for NXC-201 vs competitors.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle2 hits
23
The slide uses a two-column layout to contrast clinical results for Multiple Myeloma vs. AL Amyloidosis, supported by market data for existing therapies.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution2 hits